#United States #San Francisco #AI Data #Snowflake #Benchling

Benchling Introduces Direct Data Share for Enhanced Data Connectivity

On October 15, 2026, Benchling announced the launch of its latest feature, Direct Data Share, designed to transform how research and development teams manage scientific data in collaboration with Snowflake, the AI Data Cloud. This forward-thinking capability creates a seamless connection between Benchling's platform and the Snowflake environment, ensuring that scientific data remains current and usable in real-time.

The Significance of Direct Data Share

In today’s biotechnology landscape, where artificial intelligence becomes increasingly integral to research and development (R&D), the need for timely and reliable scientific data is paramount. Direct Data Share achieves this by enabling a bi-directional data flow between Benchling and Snowflake, allowing experimental data stored in Benchling to be readily accessible in Snowflake as dynamically refreshed tables. In return, data from instruments, assays, and computational analyses contained within Snowflake can flow back into Benchling, enriched by the experimental context that provides it significance.

Streamlined Setup for IT and Data Teams

For IT departments and data teams, this feature offers a simplified, one-time setup process. By connecting a Snowflake account, Benchling users can create a direct link that feeds scientific data into Snowflake automatically. There’s no requirement for custom export pipelines; Benchling continually provisions data to ensure accuracy and relevance. Admins can control synchronization and manage access, preserving compliance and security requirements throughout the process.

Creating a Continuous R&D Data Cycle

One of the standout benefits of Direct Data Share is its role in establishing a continuous R&D data loop. This technology ensures that the data generated from experiments flow seamlessly into analytical frameworks. As Derek Halliday, Benchling’s Head of Product, articulated, the efficiency of this data synchronization is crucial for fruitful decision-making. The integration not only facilitates timely data availability but also empowers scientists and IT teams to adapt to the evolving needs of the modern lab.

Snowflake’s Head of Healthcare and Life Sciences, Jesse Cugliotta, emphasized the broader implications of this connection: “When teams can work with experimental data alongside their organization's other datasets, the true value of scientific data is unlocked.” The synergy between Benchling and Snowflake enables biotech companies to maintain governed datasets continuously available for analysis and AI applications, fostering better decision-makings processes.

Enhancing Research with AI Connectors

Building on the momentum of its AI Connectors, which were launched earlier in the year, Direct Data Share addresses varied methodologies in handling scientific data. While AI Connectors facilitate interactive data retrieval, Direct Data Share emphasizes the importance of continuous, large-scale data analysis that allows researchers to query millions of data rows efficiently.

Availability

Direct Data Share is now available to Benchling customers as part of a public beta. Clients interested in exploring this innovative feature can reach out to their Benchling account teams or customer success managers for further engagement.

About Benchling

Benchling, a trailblazer in AI-driven solutions for biotech research and development, focuses on integrating scientific data and automating workflows to hasten discovery and product development. With a testament to its credibility, Benchling is utilized by over 1,300 organizations globally, including renowned companies such as Merck, Moderna, and Sanofi. The platform allows scientists to capture, connect, and act on data throughout the entire R&D lifecycle, ultimately resulting in more efficient teams and accelerated scientific breakthroughs.

Contact Benchling today to learn more about how Direct Data Share can enhance your scientific workflows and elevate your R&D capabilities.